The enterprise sales cycle in healthcare is the stretch from your first qualified meeting with a health system to a signed contract. For healthcare SaaS it commonly runs from several months to well over a year, because a clinical champion, IT security, legal, finance and executive leadership each have to say yes, usually in a budget calendar you do not control.
I have sat on both sides of that table: as a physician who evaluates technology, and as an advisor to founders who sell it. The founders who shorten the cycle are rarely the best closers. They understand how a hospital decides, and they prepare for each gate before the buyer reaches it.
TL;DR
- A 2026 analysis of 1,062 closed-won healthcare SaaS contracts found a median of 178 days from first qualified meeting to signature, with a wide range of 81 to 313 days between the quartiles.
- Multi-hospital systems and academic medical centers sit well above that median, at 362 and 326 days respectively.
- Most of the time is spent in clinical evaluation, security and privacy review, and contracting, not in negotiating price.
- Budget calendars matter: miss a capital planning window and the deal can slip to the next fiscal year.
- Run gates in parallel, name a clinical champion early, and prepare security and contracting documents before they are requested.
Table of Contents
- What the healthcare enterprise sales cycle actually is
- How long the cycle runs
- The stages, and how long each one takes
- Who is in the room
- Budget timing can matter more than the sales process
- Why deals stall, and what to do about it
- A worked example of preparing for the cycle
- Our perspective
- How we help healthcare SaaS teams shorten the path
- FAQ
- Sources
What the healthcare enterprise sales cycle actually is
In most industries, an enterprise sale means a long process with a buying committee. In healthcare, the committee is larger, the risk is higher and the gates are less negotiable. A product that touches clinical workflow, patient data or the EHR can affect patient safety, privacy compliance and revenue, so each group involved protects a different kind of risk.
That is why a standard SaaS playbook underperforms here. A generic sales process assumes a single economic buyer who weighs ROI and decides. A health system has a clinical lead who cares about workflow, a CMIO or informatics group who cares about the EHR, a security team who cares about PHI, a finance leader who cares about budget timing, and a legal team who cares about liability. Any one of them can stop the deal, and none of them reports to the others.
The practical consequence: your sales cycle is the sum of several internal approval processes, many of which run on their own calendars. Your job is to see them early and keep them moving at the same time.
How long the cycle runs
Published figures vary with how each source defines start and end, and with who the buyer is. The most useful recent dataset I know of is HIR Research's 2026 analysis of 1,062 closed-won healthcare SaaS contracts. It measured from first qualified meeting to signed contract and found a median of 178 days, with an interquartile range of 81 to 313 days. The same research reports a 362-day median for multi-hospital systems and a 326-day median for academic medical centers.
Note what those numbers are: deals that closed. Deals that stall or die are not in a closed-won sample, so the real experience of a team selling into large systems is often longer and less predictable than any median.
Buyer type and product type both move the number.
| Buyer or product | Typical cycle reported | Source |
|---|---|---|
| All healthcare SaaS, closed-won sample | 178 days median (81 to 313 days interquartile range) | HIR Research, 2026 |
| Multi-hospital systems | 362 days median | HIR Research, 2026 |
| Academic medical centers | 326 days median | HIR Research, 2026 |
| AI purchases at health systems | 6.6 months average, versus 8.0 months for traditional IT | Menlo Ventures data, as reported by Enter Health |
| Outpatient providers | 4.7 months for AI, versus 6.0 months for traditional IT | Menlo Ventures data, as reported by Enter Health |
Two takeaways. First, plan runway around the buyer you actually target. A seed-stage company that sells to a large academic center and budgets for a six-month cycle will run short of cash. Second, smaller buyers such as outpatient practices move faster, which is why many early-stage companies prove the product there before moving up-market. How the same data breaks down for AI and traditional IT is a useful reminder that how familiar a purchase feels to the buyer affects speed, and that purchasing timelines differ between health systems and outpatient providers. Controls like those described in this guide to HIPAA compliant AI controls are part of why newer AI tools get scrutiny that conventional IT purchases may not.
The stages, and how long each one takes
Every system names its gates differently, but the sequence is consistent. HIR Research reports median durations by stage, which gives you a realistic map.
| Stage | Median duration |
|---|---|
| Discovery and qualification | 25 days |
| Clinical or department evaluation | 32 days |
| Security and privacy review | 39 days |
| IT integration review | 22 days |
| Legal and contracting | 30 days |
| Committee or board approval | 21 days |
| Signature and countersignature | 9 days |
Source for all rows: HIR Research, 2026.
The stages add up to more than the median cycle, which tells you something important: they overlap in the deals that close well. Sequential handling is what turns a six-month deal into an eighteen-month one.
Discovery and qualification
This is where most avoidable delay is created. Discovery should settle who holds budget authority, the buying window, whether the purchase is capital or operating spend, whether a group purchasing arrangement constrains the vendor choice, and what EHR integration is required. If you leave without those answers, you are in a conversation, not a pipeline.
The questions matter more than the pitch. A set of well-built discovery questions for SaaS sales is a good starting point, and in healthcare I would add three: who owns the clinical problem, who signs off on PHI handling, and what happened the last time this organization bought something similar.
Clinical evaluation or pilot
Hospitals often want a demonstration, a pilot or a limited trial before they commit. A pilot is where deals are won and where they quietly die. Pilots work best with clear success metrics, a defined timeline and conversion criteria agreed before the pilot starts. A pilot with no agreed endpoint becomes a free, open-ended deployment.
From my clinical side: define success in terms a clinician would recognize. Minutes saved per encounter, reduced inbox burden, fewer missed follow-ups. "Engagement" and "adoption" mean little to a physician leader deciding whether to spend political capital.
Security, privacy and integration review
These gates are technical and binary. You pass or you wait. Security questionnaires, HIPAA review and business associate agreement negotiation run on the health system's queue, and in the HIR data security and privacy review is the longest single stage at a median of 39 days. Integration review adds a median of 22 more.
Have your security documentation, your BAA position and your architecture diagram ready before anyone asks. The integration side deserves the same preparation: we have written about how to halve EHR integration time with a workflow-first strategy, and the core idea is to scope integration around the clinical workflow rather than around the maximum technical surface.
Legal, contracting and signature
Contracting covers pricing, terms, implementation timelines, service and warranty language, and any purchasing-organization requirements, as described here. Founders often treat this as a formality. It is not. The first time a health system's legal team sees your paper should not be after verbal approval. For a practical walkthrough, see our 30/90/180 day playbook for hospital contracting.
Who is in the room
The 2025 HIT Buyer's Survey gives a clear picture of the committee. IT was involved in 95% of technology purchases, executive leadership in 76% and finance in 73%, with clinicians and operations also contributing. It also found that 34% of organizations involve five to nine people in a technology purchase and 23% involve ten or more, so 57% involve more than five participants.
Each person needs something different from you:
- Clinical champion: proof that the product fits real workflow and does not add clicks. This person sponsors you internally and needs ammunition.
- CMIO or informatics lead: clarity on EHR integration, data flow, alert burden and governance.
- IT and security: architecture, access controls, PHI handling, audit logging, a clear BAA position.
- Finance: a budget line, a payback logic, and where the money comes from.
- Legal and compliance: acceptable liability and data terms, regulatory posture.
- Executive leadership: strategic alignment, risk and a clear case that the problem is a priority this year.
A single enthusiastic champion is not a buying committee. Many stalled deals have one loud supporter and four silent stakeholders nobody has met. Map the full group in the first few weeks and ask your champion who else will weigh in.
Budget timing can matter more than the sales process
You can run a perfect process and still wait, because the money is not available until the next budget cycle. Many hospitals use July 1 or October 1 fiscal years and submit capital requests six to nine months before the fiscal year begins. The same guide recommends starting conversations roughly nine to twelve months before the target fiscal year, and notes that a missed planning window can push a purchase to the next budget opportunity.
So the right question is not "when do you want to buy?" but "when is your next budget submission, and what has to be true before it?" Work backward from the buyer's fiscal calendar and you will often discover that the real start of your sales cycle is months before the first meeting you would normally count. We cover this in detail in when to start selling around the health system IT budget cycle.
For a founder, the implication is a forecasting discipline. Tag every opportunity with the buyer's fiscal year and its budget window. A deal that is "closing this quarter" but missed the planning window is not closing this quarter.
Why deals stall, and what to do about it
Most healthcare deals do not die from a decisive no. They stall. The common causes are predictable.
- No clinical owner. The product is interesting, but nobody on the clinical side owns the problem.
- Pilot without an endpoint. The pilot runs, everyone is pleasant, and nothing converts.
- Security and legal found late. Reviews start after verbal approval and consume a quarter.
- Budget misalignment. The buyer likes the product but the money sits in next year's plan.
- Integration surprise. Nobody scoped the EHR work until contracting.
- Stakeholder misalignment. Clinical wants it, IT worries, finance has not been briefed.
Each has a countermeasure that a prepared vendor can build into the process from day one.
Run gates in parallel
The most effective single change is to stop handling gates in order. Start the security questionnaire while the clinical evaluation is running. Share draft contract terms as soon as pricing is on the table. Ask the buyer which reviews can begin now. Some health systems will not allow it, but many will if you ask and if your materials are ready. Industry practitioners report that parallel handling can shorten a long sequential process substantially, and in my experience, the principle holds even where the exact savings differ.
Build the business case with the buyer
The first months of a buying process often happen where you cannot see them: internal research, comparisons and business case development. Give your champion a short, clinically credible summary they can forward without editing: the problem, the evidence, the workflow impact, the cost and the risk controls. If they have to build the case from scratch, they will build it slowly.
Keep a path open while procurement proceeds
When a deal is approved in principle but procurement is slow, ask whether a limited pilot or research arrangement can proceed in parallel, if the health system permits it. That keeps clinical momentum alive and the champion engaged while formal paperwork catches up.
Qualify harder, not softer
Because cycles are long, the cost of chasing the wrong deal is high. Qualify on budget window, clinical ownership, security readiness and integration scope in the first meetings. A smaller, faster buyer who fits is worth more to an early company than a famous system with no budget this year.
A worked example of preparing for the cycle
Imagine a clinical workflow startup selling to a regional health system. In the first month, the founder confirms the buyer's fiscal year, identifies a hospitalist leader as champion and asks who from IT security and finance will weigh in. By week six, a draft pilot plan with three clinician-defined success measures is agreed. Security documentation and a BAA draft go to the health system's reviewers during the pilot, not after it. Contract terms are shared as soon as pricing is discussed. This is an illustration of the approach, not a client result, but it shows the logic: every gate is anticipated, and nothing waits for something that could have started earlier.
Our perspective
Founders often tell me their sales cycle is slow because hospitals are slow. In my experience, the cycle is usually slow because the company arrived without an answer to the question each stakeholder is silently asking.
The clinician wants to know whether this will make a shift harder. The CMIO wants to know what it does to the EHR. Security wants to know where PHI goes. Finance wants to know which budget it comes from. A founder who can answer those before they are asked is not just faster; they are trusted.
That is the gap a fractional Chief Medical Officer is built to close. We work with healthcare SaaS companies to shape the clinical strategy, evaluate the product the way a health system would, prepare the clinical evidence and pilot design, and sit alongside the founder in conversations with physician leaders and executives. With 25 years across medicine and business, I know how those conversations go from both sides of the table.
If a deal feels stuck, I would welcome a conversation about where it is waiting and why.
Paul Bergeron MD, MBA
How we help healthcare SaaS teams shorten the path
The StartUp MD is a healthcare advisory firm for SaaS and digital health companies, led by a physician with a business background. We provide Fractional Chief Medical Officer leadership and advisory engagements covering clinical strategy, product evaluation, regulatory guidance, market readiness assessment, investor support and board advising. If your pipeline has long, uncertain healthcare deals and you want a physician leader who can help you prepare for each gate, see our Fractional CMO and advisory services.
Investors with healthtech portfolio companies can use the same support to review go-to-market readiness before a team commits more spend to a long enterprise motion. You can start from our main site.
FAQ
How long is the enterprise sales cycle in healthcare?
It depends on the buyer and the product. A 2026 analysis of closed-won healthcare SaaS contracts found a 178-day median, while multi-hospital systems reached a 362-day median and academic medical centers 326 days. Plan runway for the buyer type you actually target, not the overall average.
Why are healthcare sales cycles longer than other SaaS cycles?
More stakeholders, higher risk and fixed review gates. Surveys show that most organizations involve more than five people in technology purchases, and clinical, security, privacy and legal reviews each run on their own timelines. Budget calendars add further waiting.
When should a startup begin selling to a hospital?
Earlier than feels natural. Many hospitals plan capital requests six to nine months before their fiscal year starts, and guidance suggests opening conversations nine to twelve months ahead. Learn the buyer's fiscal calendar in the first meeting.
Can a healthtech company shorten the cycle?
Yes, mostly by removing avoidable delay rather than pushing harder. Identify a clinical champion, define pilot success metrics up front, prepare security and contracting materials early and run reviews in parallel where the health system allows it.
What is the biggest reason healthcare deals stall?
Misalignment among stakeholders, usually a champion who is enthusiastic while IT, finance or legal have not been engaged. Mapping the full buying group early and addressing each person's concern is the most reliable countermeasure.
Sources
- HIR Research: Healthcare SaaS Sales Cycle Length Statistics, 2026
- Enter Health: The State of AI in Healthcare RCM
- HIT Buyer's Survey 2025
- What Is the Healthcare Sales Cycle?
- Hospital Procurement Guide